Ultophy Side Effects

Xultophy® 100/3.6 | Xultophy® 100/3.6 (insulin Degludec And ...
What is the most important information I should know about Xultophy ® 100/3.6?. Xultophy ® 100/3.6 may cause serious side effects, including:. Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. ... Access Full Source

A Proven Step To Reach Your A1C Goal - NovoMedLink
Clinical studies for ultophy Xultophy® 100/3.6 may cause serious side effects that can be life-threatening, including: · ®inflammation of your pancreas (pancreatitis). Stop using Xultophy 100/3.6 and call your health care provider right away if you have severe pain in your ... Return Document

Xultophy, INN-insulin Degludec/liraglutide
A neutral effect on body weight. The most com mon side effects are hypoglycaemia and gastrointestinal adverse reactions such as nausea and diarrhoea. A pharmacovigilance plan for Xultophy will be implemented as part of the marketing authorisation. The approved indication is: " Xultophy is indicated for the treatment of adults with type 2 diabetes ... Read Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION GLP-1 Receptor Agonist ...
• Effects of delayed gastric emptying on oral medications: May impact absorption of concomitantly administered oral medications (7.2). ——— USE IN SPECIFIC POPULATIONS ——— Pregnancy: XULTOPHY ® 100/3.6 should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus (8.1). ... Fetch Content

Xultophy.com - Xultophy® 100/3.6 | Xultophy® 100/3.6 (insulin ...
Xultophy.com : xultophy® 100/3.6 is a medicine that combines insulin degludec and liraglutide. read important safety information, including boxed warning, on this page. ... Fetch Full Source

Xultophy 100/3.6 Dosage Guide - Drugs.com
Titration of XULTOPHY 100/3.6 • After starting the recommended starting dose of XULTOPHY 100/3.6 [see Dosage and Administration ()], titrate the dosage upwards or downwards by two units (see Table 2) every three to four days based on the patient’s metabolic needs, blood glucose monitoring results, and glycemic control goal until the desired fasting plasma glucose is achieved. ... Content Retrieval

Xultophy Injection: Uses, Dosage & Side Effects - Drugs.com
Xultophy is an injection pen containing a combination of insulin degludec and liraglutide. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin degludec is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. ... Fetch This Document